Biotangents Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Liquidation

Biotangents General Information

Description

Developer a veterinary diagnostic device designed to detect a variety of infectious diseases in livestock. The company's device uses an isothermal amplification technology that offers molecular precision without technical demands and can be rapidly adapted to new targets with ease, enabling clients to reduce the impact of infectious diseases on livestock farming offering animal protein to be produced efficiently.

Contact Information

Website
www.biotangents.co.uk
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 14/15 Doherty Innovation Centre
  • Pentlands Science Park, Bush Loan
  • Penicuik EH26 0PZ
  • Scotland, United Kingdom
+44 0131
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Products
Vertical(s)
Life Sciences
Corporate Office
  • 14/15 Doherty Innovation Centre
  • Pentlands Science Park, Bush Loan
  • Penicuik EH26 0PZ
  • Scotland, United Kingdom
+44 0131

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotangents Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Bankruptcy: Liquidation 23-Jul-2026 Completed Bankruptcy: Liquidation
11. Later Stage VC 28-Nov-2024 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC 23-Dec-2022 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
7. Early Stage VC 06-May-2019 Completed Generating Revenue
6. Grant 01-Jan-2019 Completed Generating Revenue
5. Early Stage VC 28-Mar-2018 Completed Generating Revenue
4. Grant 04-Dec-2017 $504K $117K Completed Generating Revenue
3. Seed Round 30-Mar-2017 $117K $117K Completed Generating Revenue
To view Biotangents’s complete valuation and funding history, request access »

Biotangents Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 5,589 $0.012158 $107.88 $107.88 1x $107.88 12.59%
Ordinary 1,267 $0.012158 $91.19 $91.19 1x $91.19 2.85%
To view Biotangents’s complete cap table history, request access »

Biotangents Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer a veterinary diagnostic device designed to detect a variety of infectious diseases in livestock. The company's
Diagnostic Equipment
Penicuik, United Kingdom
12 As of 2025

Mascot, Australia
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biotangents Competitors (2)

One of Biotangents’s 2 competitors is AusDiagnostics, a Formerly PE-Backed company based in Mascot, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AusDiagnostics Formerly PE-Backed Mascot, Australia
InBios International Corporation Seattle, WA
You’re viewing 2 of 2 competitors. Get the full list »

Biotangents Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Biotangents Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202403821-D0 Probes, primers and methods for nucleic acid detection Inactive 18-Mar-2024
WO-2025196414-A1 Probes, primers and methods for nucleic acid detection Pending 18-Mar-2024
GB-202401017-D0 Apparatus auitable for preparing a sample for analysis Pending 19-Jan-2024
GB-2637356-A Apparatus suitable for preparing a sample for analysis Pending 19-Jan-2024
WO-2025153796-A1 Apparatus suitable for preparing a sample for analysis Pending 19-Jan-2024 B01L3/50825
To view Biotangents’s complete patent history, request access »

Biotangents Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Biotangents FAQs

  • When was Biotangents founded?

    Biotangents was founded in 2015.

  • Where is Biotangents headquartered?

    Biotangents is headquartered in Penicuik, United Kingdom.

  • What is the size of Biotangents?

    Biotangents has 12 total employees.

  • What industry is Biotangents in?

    Biotangents’s primary industry is Diagnostic Equipment.

  • Is Biotangents a private or public company?

    Biotangents is a Private company.

  • What is Biotangents’s current revenue?

    The current revenue for Biotangents is .

  • How much funding has Biotangents raised over time?

    Biotangents has raised $9.1M.

  • Who are Biotangents’s competitors?

    AusDiagnostics and InBios International are competitors of Biotangents.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process